trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Chloroquine has well-documented safety data and adverse effect profiles

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Chloroquine possesses well-documented safety data and adverse effect profiles, supported by extensive clinical use and pharmacovigilance studies detailing risks such as ocular and cardiac events.

The analysis

The retrieved literature extensively documents the safety profile, adverse events, and pharmacovigilance data associated with chloroquine (and its derivative hydroxychloroquine) across multiple clinical contexts like autoimmune and rheumatic diseases. The evidence consistently describes well-characterized risks (e.g., ocular, cardiac, and neuropsychiatric events), directly supporting the claim that its safety data and adverse effect profiles are well-documented.

Evidence for · 4
Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases.
Recorded source metadata

Al-Hamadani M, Darweesh M, Mohammadi S, Al-Harrasi A. Chloroquine and hydroxychloroquine: Immunomodulatory effects in autoimmune diseases.. 2025. https://doi.org/10.4331/wjbc.v16.i2.107042

Discusses the established clinical applications and long-term side effects of chloroquine and hydroxychloroquine in managing autoimmune diseases.

See more details
More for · 3
Safety profile of chloroquine and hydroxychloroquine: an analysis of the FDA Adverse Event Reporting System (FAERS) database
Recorded source metadata

Georgios Papazisis, Spyridon Siafis, Dainora Cepaityte, Dimitrios Giannis, Dimitrios Tzachanis, Antoine Egberts. Safety profile of chloroquine and hydroxychloroquine: an analysis of the FDA Adverse Event Reporting System (FAERS) database. 2020. https://doi.org/10.22541/au.158991643.34704253

Analyzes the safety profile and adverse events of chloroquine using real-world FDA pharmacovigilance data.

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS).
Recorded source metadata

Li X, Zhang SQ, Wang KR, Wu SN, Wang MY, Chen CT, Dong N. Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS).. 2025. https://doi.org/10.3389/fphar.2025.1498814

Provides real-world evidence from the FAERS database regarding the ocular safety profile and specific risks associated with chloroquine and hydroxychloroquine.

The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review.
Recorded source metadata

Ates I, Sahin H, Irham LM, Yilmaz S, Suzen S. The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review.. 2025. https://doi.org/10.1111/bcpt.70082

Notes that while widely regarded as safe for rheumatic disorders, chloroquine and hydroxychloroquine have well-documented potential side effects requiring careful evaluation.

The paper trail · every fact has a biography
first checked02 Aug 2026
judged → SUPPORTED · 8002 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt